News

Abatacept is indicated across multiple inflammatory conditions, including for the treatment of adult patients with moderately to severely active rheumatoid arthritis, pediatric patients with moderately to severely active polyarticular juvenile idiopathic arthritis, and active juvenile psoriatic arthritis.

Furmonertinib is in development for the treatment of advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.

The FDA granted Wezlana with interchangeable designation after clinical trials found no clinically significant differences in safety and efficacy for the indicated conditions across multiple inflammatory diseases.

The approval of pembrolizumab (Keytruda; Merck) combined with gemcitabine and cisplatin for the treatment locally advanced unresectable or metastatic biliary tract cancer is the sixth sixth indication for the anti-PD-1 therapy for gastrointestinal cancers.

Collaboration provides both organizations opportunities to accelerate growth, streamline processes, and enhance data integrity.

Findings offer promising implications for neuroscience clinical trials and future treatments, company says.

Gill discusses her continuing work to transform clinical trials and improve the patient experience through DCTs.

Companies aim to simplify access to informative patient care data.

How pharma companies can reduce the risk of failure with AI-based innovations.

Organizations aim to advance precision oncology and biomarker-driven research.

Support to focus on two double-blind Phase IIIb clinical studies in the Democratic Republic of Congo and Cote d’Ivoire.

Initiative aims to reduce cancer mortality rates by 50% in the next 25 years.

Mixture to be used for central nervous system clinical trials.

Industry leaders gathered to address the current landscape of data collection in clinical trials.

Collaboration to focus on enhancing physician engagement in clinical trials and cancer research.

The ACT EU initiative aims to develop the European Union further as a competitive center for innovative clinical research.

Treatment facility to be the first to evaluate Deltacel for patients with non-small cell lung cancer.

Collaboration to focus on enabling clinicians to open clinical trials at the point of care.

Partnership enables Moderna to leverage Caris' library of de-identified, multi-modal data and analytics.

Company to integrate European diversity data from the UK and demographics data from France and Spain.

New hires expected to reinforce the company's clinical and digital trial expertise.

Move marks commitment to leading the frontier of AI-driven innovation and simulation in life sciences, company says.

Two-thirds of respondents believe setup and training on trial sponsor technology are more problematic than five years ago.

Service expected to offer insights to sponsors conducting clinical trials in any indication in under ten days.

Added feature offers cost savings and the ability to reduce carbon footprint, company says.

CRO commits to achieving Net-Zero Standard by 2035.

Aims to advance innovative treatments for rare diseases.

Companies to collaborate on facilitating clinical trials in historically underserved regions.